Mark A. Kay

Mark A. Kay

Stanford University

H-index: 120

North America-United States

About Mark A. Kay

Mark A. Kay, With an exceptional h-index of 120 and a recent h-index of 58 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Gene therapy, Non coding RNAs, Genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors

Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer

Selection of viral capsids and promoters affects the efficacy of rescue of Tmprss3-deficient cochlea

A standardized ontology for naming tRNA-derived RNAs based on molecular origin

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors

Mark A. Kay Information

University

Position

___

Citations(all)

61434

Citations(since 2020)

14386

Cited By

52679

hIndex(all)

120

hIndex(since 2020)

58

i10Index(all)

304

i10Index(since 2020)

198

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Mark A. Kay Skills & Research Interests

Gene therapy

Non coding RNAs

Genetics

Top articles of Mark A. Kay

Title

Journal

Author(s)

Publication Date

Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors

Nature Biotechnology

Fabian P Suchy

Daiki Karigane

Yusuke Nakauchi

Maimi Higuchi

Jinyu Zhang

...

2024/4/8

Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

2019/8/20

Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism

2016/12/2

Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer

Molecular Therapy-Nucleic Acids

Francesco Puzzo

Chuanling Zhang

Bethany Powell Gray

Feijie Zhang

Bruce A Sullenger

...

2023/3/14

Selection of viral capsids and promoters affects the efficacy of rescue of Tmprss3-deficient cochlea

Molecular Therapy-Methods & Clinical Development

Ksenia A Aaron

Katja Pekrun

Patrick J Atkinson

Sara E Billings

Julia M Abitbol

...

2023/9/14

A standardized ontology for naming tRNA-derived RNAs based on molecular origin

Nature methods

Andrew D Holmes

Patricia P Chan

Qi Chen

Pavel Ivanov

Laurence Drouard

...

2023/5

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner

Nature Communications

Adriana Gonzalez-Sandoval

Katja Pekrun

Shinnosuke Tsuji

Feijie Zhang

King L Hung

...

2023/4/28

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors

Frontiers in Immunology

Meredith E Davis-Gardner

Jesse A Weber

Jun Xie

Katja Pekrun

Eric A Alexander

...

2023/4/21

Capsid-mediated chromatin state of the AAV vector genome controls host species range

bioRxiv

Adriana Gonzalez-Sandoval

Shinnosuke Tsuji

Feijie Zhang

King L Hung

Howard Y Chang

...

2022/10/6

Using Recombinant Adeno-Associated Viral Vectors for Long-Term Expression of a Hyperactive Human Factor IX Mutant in Hemophilic Mice and Comparison of AAV-LK03 and AAV-KP1 in …

Anke Van der Perren

Jaan Toelen

Jean-Marc Taymans

Veerle Baekelandt

2012

Methods And Compositions For Enhancing AAV-Mediated Homologous Recombination Using Ribonucleotide Reductase Inhibitors

2022/9/1

Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice

Frontiers in Genome Editing

Michela Lisjak

Alessia De Caneva

Thibaut Marais

Elena Barbon

Maria Grazia Biferi

...

2022/3/11

Selective microvascular tissue transfection using Minicircle DNA for systemic delivery of human coagulation factor IX in a rat model using a therapeutic flap

Plastic and Reconstructive Surgery

Peter A Than

Christopher R Davis

Robert C Rennert

Shane D Morrison

Michael W Findlay

...

2022/1/1

Evaluating the state of the science for adeno-associated virus integration: An integrated perspective

Denise E Sabatino

Frederic D Bushman

Randy J Chandler

Ronald G Crystal

Beverly L Davidson

...

2022/8/3

GATA4 regulates mitochondrial biogenesis and functions during cardiac development and rescues cardiac and mitochondrial functions impaired by TKIs

Qing Liu

Haodi Wu

Zhana Duren

Chao Jiang

Kevin Van Bortle

...

2022/12/9

Fludarabine increases nuclease-free AAV-and CRISPR/Cas9-mediated homologous recombination in mice

Nature biotechnology

Shinnosuke Tsuji

Calvin J Stephens

Giulia Bortolussi

Feijie Zhang

Gabriele Baj

...

2022/8

Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model

Molecular Therapy-Methods & Clinical Development

Ren Song

Katja Pekrun

Themasap A Khan

Feijie Zhang

Sergiu P Paşca

...

2022/12/8

Non-disruptive gene targeting

2022/6/30

Adeno-Associated Viral Vectors for Crossing the Human Blood Brain Barrier

2022/12/1

Improved genome editing through inhibition of FANCM and members of the BTR dissolvase complex

Molecular Therapy

Gustavo de Alencastro

Francesco Puzzo

Mara Pavel-Dinu

Feijie Zhang

Sirika Pillay

...

2021/3/3

See List of Professors in Mark A. Kay University(Stanford University)

Co-Authors

H-index: 179
Gregory Hannon

Gregory Hannon

University of Cambridge

H-index: 128
Joseph C. Wu

Joseph C. Wu

Stanford University

H-index: 99
Stephen Strom

Stephen Strom

Karolinska Institutet

H-index: 32
Paul Valdmanis

Paul Valdmanis

University of Washington

H-index: 19
Likun Xia

Likun Xia

Universiti Teknologi Petronas

H-index: 7
Neil Phillips

Neil Phillips

Vanderbilt University

academic-engine